Table of Content

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 44

3 Segmentation of Asia Pacific Market by Vaccine Type 48
3.1 Market Overview by Vaccine Type 48
3.2 Live/Attenuated Vaccines 50
3.3 Inactivated Vaccines 51
3.4 Subunit Vaccines 52
3.5 Toxoid Vaccines 53
3.6 Conjugate Vaccines 54
3.7 mRNA Vaccines 55
3.8 Recombinant Vector Vaccines 56
3.9 Other Vaccines 57

4 Segmentation of Asia Pacific Market by Disease 58
4.1 Market Overview by Disease 58
4.2 Pneumococcal Disease 60
4.3 Poliovirus 61
4.4 Hepatitis 62
4.5 Influenza 63
4.6 Measles, Mumps, and Rubella (MMR) 64
4.7 Varicella 65
4.8 Human Papilloma Virus 66
4.9 COVID-19 67
4.10 Other Diseases 68

5 Segmentation of Asia Pacific Market by Administration 69
5.1 Market Overview by Administration 69
5.2 Intramuscular Route 71
5.3 Subcutaneous Route 72
5.4 Oral Route 73
5.5 Intravenous Injection 74
5.6 Other Administration Routes 75

6 Segmentation of Asia Pacific Market by Patient 76
6.1 Market Overview by Patient 76
6.2 Pediatric Vaccines 78
6.3 Adult Vaccines 80

7 Asia-Pacific Market 2022-2032 by Country 82
7.1 Overview of Asia-Pacific Market 82
7.2 Japan 85
7.3 China 89
7.4 Australia 93
7.5 India 96
7.6 South Korea 99
7.7 Rest of APAC Region 102

8 Competitive Landscape 104
8.1 Overview of Key Vendors 104
8.2 New Product Launch, Partnership, Investment, and M&A 107
8.3 Company Profiles 108
AstraZeneca plc 108
Bavarian Nordic A/S 110
China National Biotec Group Company Ltd. 113
CSL Ltd. 115
Daiichi Sankyo Co. Ltd 117
Emergent BioSolutions Inc. 119
GlaxoSmithKline plc 121
Johnson & Johnson 125
Merck & Co. 127
Moderna Inc. 129
Novavax, Inc. 130
Pfizer Inc. 132
Sanofi SA 136
Takeda Pharmaceutical Co. Ltd. 139
RELATED REPORTS 141



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 17
Figure 4. Asia Pacific Preventive Vaccines Market, 2022-2032, $ mn 20
Figure 5. Development Stages of Preventive Vaccines 21
Figure 6. Impact of COVID-19 on Business 25
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Preventive Vaccines Market 31
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 9. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 35
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Preventive Vaccines Market 37
Figure 12. Investment Opportunity Analysis 41
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Preventive Vaccines Market 44
Figure 14. Breakdown of Asia Pacific Preventive Vaccines Market by Vaccine Type, 2022-2032, % of Revenue 49
Figure 15. Asia Pacific Addressable Market Cap in 2023-2032 by Vaccine Type, Value ($ mn) and Share (%) 49
Figure 16. Asia Pacific Preventive Vaccines Market by Vaccine Type: Live/Attenuated Vaccines, 2022-2032, $ mn 50
Figure 17. Asia Pacific Preventive Vaccines Market by Vaccine Type: Inactivated Vaccines, 2022-2032, $ mn 51
Figure 18. Asia Pacific Preventive Vaccines Market by Vaccine Type: Subunit Vaccines, 2022-2032, $ mn 52
Figure 19. Asia Pacific Preventive Vaccines Market by Vaccine Type: Toxoid Vaccines, 2022-2032, $ mn 53
Figure 20. Asia Pacific Preventive Vaccines Market by Vaccine Type: Conjugate Vaccines, 2022-2032, $ mn 54
Figure 21. Asia Pacific Preventive Vaccines Market by Vaccine Type: mRNA Vaccines, 2022-2032, $ mn 55
Figure 22. Asia Pacific Preventive Vaccines Market by Vaccine Type: Recombinant Vector Vaccines, 2022-2032, $ mn 56
Figure 23. Asia Pacific Preventive Vaccines Market by Vaccine Type: Other Vaccines, 2022-2032, $ mn 57
Figure 24. Breakdown of Asia Pacific Preventive Vaccines Market by Disease, 2022-2032, % of Sales Revenue 59
Figure 25. Asia Pacific Addressable Market Cap in 2023-2032 by Disease, Value ($ mn) and Share (%) 59
Figure 26. Asia Pacific Preventive Vaccines Market by Disease: Pneumococcal Disease, 2022-2032, $ mn 60
Figure 27. Asia Pacific Preventive Vaccines Market by Disease: Poliovirus, 2022-2032, $ mn 61
Figure 28. Asia Pacific Preventive Vaccines Market by Disease: Hepatitis, 2022-2032, $ mn 62
Figure 29. Asia Pacific Preventive Vaccines Market by Disease: Influenza, 2022-2032, $ mn 63
Figure 30. Asia Pacific Preventive Vaccines Market by Disease: Measles, Mumps, and Rubella (MMR), 2022-2032, $ mn 64
Figure 31. Asia Pacific Preventive Vaccines Market by Disease: Varicella, 2022-2032, $ mn 65
Figure 32. Asia Pacific Preventive Vaccines Market by Disease: Human Papilloma Virus, 2022-2032, $ mn 66
Figure 33. Asia Pacific Preventive Vaccines Market by Disease: COVID-19, 2022-2032, $ mn 67
Figure 34. Asia Pacific Preventive Vaccines Market by Disease: Other Diseases, 2022-2032, $ mn 68
Figure 35. Breakdown of Asia Pacific Preventive Vaccines Market by Administration, 2022-2032, % of Sales Revenue 70
Figure 36. Asia Pacific Addressable Market Cap in 2023-2032 by Administration, Value ($ mn) and Share (%) 70
Figure 37. Asia Pacific Preventive Vaccines Market by Administration: Intramuscular Route, 2022-2032, $ mn 71
Figure 38. Asia Pacific Preventive Vaccines Market by Administration: Subcutaneous Route, 2022-2032, $ mn 72
Figure 39. Asia Pacific Preventive Vaccines Market by Administration: Oral Route, 2022-2032, $ mn 73
Figure 40. Asia Pacific Preventive Vaccines Market by Administration: Intravenous Injection, 2022-2032, $ mn 74
Figure 41. Asia Pacific Preventive Vaccines Market by Administration: Other Administration Routes, 2022-2032, $ mn 75
Figure 42. Breakdown of Asia Pacific Preventive Vaccines Market by Patient, 2022-2032, % of Revenue 77
Figure 43. Asia Pacific Addressable Market Cap in 2023-2032 by Patient, Value ($ mn) and Share (%) 77
Figure 44. Asia Pacific Preventive Vaccines Market by Patient: Pediatric Vaccines, 2022-2032, $ mn 78
Figure 45. Asia Pacific Preventive Vaccines Market by Patient: Adult Vaccines, 2022-2032, $ mn 80
Figure 46. Breakdown of APAC Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 83
Figure 47. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 84
Figure 48. Preventive Vaccines Market in Japan, 2022-2032, $ mn 86
Figure 49. Preventive Vaccines Market in China, 2022-2032, $ mn 89
Figure 50. Preventive Vaccines Market in Australia, 2022-2032, $ mn 93
Figure 51. Preventive Vaccines Market in India, 2022-2032, $ mn 96
Figure 52. Preventive Vaccines Market in South Korea, 2022-2032, $ mn 99
Figure 53. Preventive Vaccines Market in Rest of APAC, 2022-2032, $ mn 102
Figure 54. Growth Stage of Asia Pacific Preventive Vaccines Industry over the Forecast Period 104

List of Tables

List of Tables:

Table 1. Snapshot of Asia Pacific Preventive Vaccines Market in Balanced Perspective, 2022-2032 18
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Preventive Vaccines Market 40
Table 7. Asia Pacific Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 48
Table 8. Asia Pacific Preventive Vaccines Market by Disease, 2022-2032, $ mn 58
Table 9. Asia Pacific Preventive Vaccines Market by Administration, 2022-2032, $ mn 69
Table 10. Asia Pacific Preventive Vaccines Market by Patient, 2022-2032, $ mn 76
Table 11. Asia Pacific Preventive Vaccines Market: Pediatric Vaccines by Disease, 2022-2032, $ mn 79
Table 12. Asia Pacific Preventive Vaccines Market: Adult Vaccines by Disease, 2022-2032, $ mn 81
Table 13. APAC Preventive Vaccines Market by Country, 2022-2032, $ mn 83
Table 14. Japan Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 87
Table 15. Japan Preventive Vaccines Market by Disease, 2022-2032, $ mn 87
Table 16. Japan Preventive Vaccines Market by Administration, 2022-2032, $ mn 88
Table 17. China Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 90
Table 18. China Preventive Vaccines Market by Disease, 2022-2032, $ mn 90
Table 19. China Preventive Vaccines Market by Administration, 2022-2032, $ mn 92
Table 20. Australia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 94
Table 21. Australia Preventive Vaccines Market by Disease, 2022-2032, $ mn 94
Table 22. Australia Preventive Vaccines Market by Administration, 2022-2032, $ mn 95
Table 23. India Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 97
Table 24. India Preventive Vaccines Market by Disease, 2022-2032, $ mn 97
Table 25. India Preventive Vaccines Market by Administration, 2022-2032, $ mn 98
Table 26. South Korea Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 100
Table 27. South Korea Preventive Vaccines Market by Disease, 2022-2032, $ mn 100
Table 28. South Korea Preventive Vaccines Market by Administration, 2022-2032, $ mn 101
Table 29. Preventive Vaccines Market in Rest of APAC by Country/Region, 2022-2032, $ mn 103
Table 30. AstraZeneca plc: Company Snapshot 108
Table 31. AstraZeneca plc: Business Segmentation 109
Table 32. AstraZeneca plc: Product Portfolio 109
Table 33. Bavarian Nordic A/S: Company Snapshot 110
Table 34. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020 111
Table 35. China National Biotec Group Company Ltd.: Company Snapshot 113
Table 36. CSL Ltd.: Company Snapshot 115
Table 37. Daiichi Sankyo Co. Ltd.: Company Snapshot 117
Table 38. Emergent BioSolutions Inc.: Company Snapshot 119
Table 39. GlaxoSmithKline: Company Snapshot 121
Table 40. GlaxoSmithKline: Business Segmentation 122
Table 41. GlaxoSmithKline: Product Portfolio 123
Table 42. GlaxoSmithKline: Revenue, 2018-2020, $ bn 124
Table 43. GlaxoSmithKline: Recent Developments 124
Table 44. Johnson & Johnson: Company Snapshot 125
Table 45. Johnson & Johnson: Business Segments 126
Table 46. Merck & Co., Inc.: Company Snapshot 127
Table 47. Merck & Co., Inc.: Business Segmentation 127
Table 48. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 128
Table 49. Moderna Inc.: Company Snapshot 129
Table 50. Novavax, Inc.: Company Snapshot 130
Table 51. Pfizer Inc.: Company Snapshot 132
Table 52. Pfizer Inc.: Business Segmentation 133
Table 53. Pfizer Inc.: Product Portfolio 134
Table 54. Pfizer Inc.: Revenue, 2018-2020, $ bn 135
Table 55. Pfizer Inc.: Recent Developments 135
Table 56. Sanofi: Company Snapshot 136
Table 57. Sanofi: Business Segmentation 136
Table 58. Sanofi: Revenue, 2018-2020, $ bn 138
Table 59. Takeda Pharmaceutical Co. Ltd.: Company Snapshot 139